In 2001, Kelley et al. [28] studied the function of the Ape1/ref-1 enzyme in the risk of Pca, which suggested that this enzyme might be a diagnostic marker for early Pca and play a role in the physiology of the early development of this disease. The gene discussed is APEX1; the disease is posterior cortical atrophy.